Refractory coeliac disease: remission with infliximab and immunomodulators

SM Turner, M Moorghen, C Probert

Research output: Contribution to journalArticle (Academic Journal)peer-review

37 Citations (Scopus)

Abstract

Coeliac disease is a T-cell-mediated enteropathy induced by gluten. A minority of patients who fail to respond to a gluten-free diet may require intervention with immunomodulating drugs. We report a case of refractory coeliac disease where remission was induced by the anti-tumour necrosis factor-alpha antibody infliximab and was maintained with prednisolone and azathioprine.
Translated title of the contributionRefractory coeliac disease: remission with infliximab and immunomodulators
Original languageEnglish
Pages (from-to)667 - 669
Number of pages3
JournalEuropean Journal of Gastroenterology and Hepatology
Volume17(6)
Publication statusPublished - Jun 2005

Fingerprint Dive into the research topics of 'Refractory coeliac disease: remission with infliximab and immunomodulators'. Together they form a unique fingerprint.

Cite this